In Medtronic’s spinal sector, revenue from core spinal products, including Kyphon, increased 2 percent and biologics revenue grew 12 percent, both on a constant currency basis.
Outside the United States, the company’s spinal revenue grew 10 percent on a constant currency basis, driven by solid growth everywhere except Europe.
Read the release on Medtronic’s Q3 spinal revenue.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
